103 related articles for article (PubMed ID: 11675825)
21. Clinical data: AVERT and QUO VADIS.
O'Neill BJ
Can J Cardiol; 2000 Aug; 16 Suppl E():32E-35E. PubMed ID: 10906624
[TBL] [Abstract][Full Text] [Related]
22. Rationale for ACE inhibition as an anti-ischaemic therapy.
Pepine CJ
Eur Heart J; 1998 Jul; 19 Suppl G():G34-40. PubMed ID: 9717054
[TBL] [Abstract][Full Text] [Related]
23. BANFF: an update.
Anderson T
Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
[TBL] [Abstract][Full Text] [Related]
24. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
[TBL] [Abstract][Full Text] [Related]
25. ACE gene polymorphism and coronary restenosis.
Bauters C; Amouyel P; Bertrand ME
Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
[TBL] [Abstract][Full Text] [Related]
26. The race for ACE: a simple answer to the controversial puzzle of angiotensin-converting enzyme (ACE) polymorphisms.
Schieffer B; Drexler H
J Am Coll Cardiol; 2003 Jun; 41(11):1962-3. PubMed ID: 12798566
[No Abstract] [Full Text] [Related]
27. [Diabetic polyneuropathy and ACE gene polymorphism].
Yasuda H
Nihon Rinsho; 2005 Jun; 63 Suppl 6():652-6. PubMed ID: 15999786
[No Abstract] [Full Text] [Related]
28. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
[TBL] [Abstract][Full Text] [Related]
29. Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.
Lough M; Cleland J; Langan J; Cowley A; Wade A
BMJ; 1998 Nov; 317(7169):1352-3. PubMed ID: 9812933
[No Abstract] [Full Text] [Related]
30. Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting.
Martínez-Ríos MA; Alvarez-León E; Totomoch A; Angeles J; Peña-Duque MA; Delgadillo-Rodríguez H; Martínez-Rodríguez N; Ramírez-Fuentes S; Fragoso JM; Vargas-Alarcón G
Exp Mol Pathol; 2014 Aug; 97(1):166-70. PubMed ID: 24995885
[TBL] [Abstract][Full Text] [Related]
31. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
[No Abstract] [Full Text] [Related]
32. A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
Chen WH; Kaul U; Leung SK; Lau YK; Tan HC; Leung AW; Lee MK; Li SK; Ng W; Lee PY; Lam KF; Tse HF; Lau CP
J Invasive Cardiol; 2005 Oct; 17(10):534-8. PubMed ID: 16204748
[TBL] [Abstract][Full Text] [Related]
33. [PROGRESS].
Hasegawa Y
Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
[No Abstract] [Full Text] [Related]
34. Angiotensin converting enzyme inhibitors and restenosis: let's stop teasing ourselves.
Mancini GB
Cardiovasc Drugs Ther; 2001 Jul; 15(4):293-5. PubMed ID: 11800410
[No Abstract] [Full Text] [Related]
35. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale.
Warnica JW; Gilst WV; Baillot R; Johnstone D; Block P; Myers MG; Chocron S; Ave SD; Martineau P; Rouleau JL
Can J Cardiol; 2002 Nov; 18(11):1191-200. PubMed ID: 12464983
[TBL] [Abstract][Full Text] [Related]
36. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
[TBL] [Abstract][Full Text] [Related]
37. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.
Ryu SK; Cho EY; Park HY; Im EK; Jang YS; Shin GJ; Shim WH; Cho SY
Yonsei Med J; 2002 Aug; 43(4):461-72. PubMed ID: 12205735
[TBL] [Abstract][Full Text] [Related]
38. No association found between the insertion/deletion of a 287-bp alu repeat sequence within intron 16 of the angiotensin-I-converting enzyme (ACE) gene in Mexican patients and binary restenosis after coronary stenting.
Martínez-Ríos MA; Peña-Duque MA; Fragoso JM; Delgadillo-Rodríguez H; Pérez-Hernández N; Miranda-Malpica E; Rodríguez-Pérez JM; González-Quesada C; Vargas-Alarcón G
Clin Chim Acta; 2008 Nov; 397(1-2):65-7. PubMed ID: 18706898
[TBL] [Abstract][Full Text] [Related]
39. Moexipril: another ACE inhibitor for hypertension.
Med Lett Drugs Ther; 1995 Sep; 37(956):75-6. PubMed ID: 7637658
[No Abstract] [Full Text] [Related]
40. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
Bauters C; Amouyel P
Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
